Question 1

What specific tests will be done to monitor my molecular residual disease?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic Cancer clinical trial (NCT05802394). Contact the study team or your healthcare provider for specific answers.

Question 2

How might the results of these tests change my treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic Cancer clinical trial (NCT05802394). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of the later-line therapies I might receive?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic Cancer clinical trial (NCT05802394). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for blood tests and imaging assessments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic Cancer clinical trial (NCT05802394). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic Cancer clinical trial (NCT05802394). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic Cancer clinical trial (NCT05802394). Contact the study team or your healthcare provider for specific answers.

What this study is about